Riley Ennis is co-founder of Freenome. Prior to starting Freenome, Ennis founded the biotech startup Immudicon, which is based on three years of research that he started in high school on a cancer vaccine technology that teaches the immune cells of the body to recognize and remove tumors. He has been recognized by CNN, Google X, TEDx, J&J, SXSW, the American Society of Microbiology, the National Cancer Institute, Verizon Powerful Answers, Fox News, the GE Focus Forward Competition, the Intel International Science Fair and the National Young Inventors Gallery. Ennis began a Thiel Fellowship in 2013. He’s a graduate of Dartmouth College, where he earned a double major in economics and biology and worked at the Dartmouth Hitchcock-Medical Center on cancer nanotechnology research projects as a Dartmouth science scholar. He is also a member of the Kairos Society for young entrepreneurs.